A PILOT-STUDY OF IMMUNIZATION WITH INTERLEUKIN-2 SECRETING ALLOGENEIC HLA-A2 MATCHED RENAL-CELL CARCINOMA-CELLS IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA

被引:28
|
作者
GANSBACHER, B
MOTZER, R
HOUGHTON, A
BANDER, N
MINASIAN, L
GASTL, G
ROSENTHAL, F
GILBOA, E
SCHEINFELD, J
YANG, SY
WONG, G
GOLDE, D
REUTER, V
LIVINGSTON, P
BOSL, G
NANUS, D
FAIR, WR
机构
关键词
D O I
10.1089/hum.1992.3.6-691
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:691 / 703
页数:13
相关论文
共 50 条
  • [21] IMMUNOLOGICAL STUDY OF HUMAN RECOMBINANT INTERLEUKIN-2 (LOW-DOSE) IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
    MARUMO, K
    MURAKI, J
    UENO, M
    TACHIBANA, M
    DEGUCHI, N
    BABA, S
    JITSUKAWA, S
    HATA, M
    TAZAKI, H
    UROLOGY, 1989, 33 (03) : 219 - 225
  • [22] RECOMBINANT INTERFERON-ALPHA-2A AND INTERLEUKIN-2 IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    JURINCICWINKLER, C
    HORLBECK, R
    KLIPPEL, KF
    WIENER KLINISCHE WOCHENSCHRIFT, 1993, 105 (10) : 271 - 276
  • [23] THE EFFECTS OF ORAL PENTOXIFYLLINE ON INTERLEUKIN-2 TOXICITY IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    ANDERSON, JA
    WOODCOCK, TM
    HARTY, JI
    KNOTT, AW
    EDWARDS, MJ
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (05) : 714 - 717
  • [24] ALPHA-INTERFERON AND INTERLEUKIN-2 IN RENAL-CELL CARCINOMA - STUDIES IN NONHOSPITALIZED PATIENTS
    ATZPODIEN, J
    POLIWODA, H
    KIRCHNER, H
    SEMINARS IN ONCOLOGY, 1991, 18 (05) : 108 - 112
  • [25] TREATMENT OF PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
    AULITZKY, WE
    HUBER, C
    ONKOLOGIE, 1994, 17 (04): : 437 - 437
  • [26] HIGH-DOSE INTERLEUKIN-2 IN THE THERAPY OF METASTATIC RENAL-CELL CARCINOMA
    PARKINSON, DR
    SZNOL, M
    SEMINARS IN ONCOLOGY, 1995, 22 (01) : 61 - 66
  • [27] SEQUENTIAL INTERLEUKIN-2 AND ALPHA-INTERFERON FOR RENAL-CELL CARCINOMA AND MELANOMA
    THOMAS, H
    BARTON, C
    SAINI, A
    DALGLEISH, A
    WAXMAN, J
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (6-7) : 1047 - 1049
  • [28] REVERSIBLE NEUROTOXICITY DURING INTERLEUKIN-2 THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    VANLAAR, JM
    VANBUCHEM, MA
    WEYL, N
    CLETON, FJ
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (11) : 1895 - 1897
  • [29] LOW-DOSE INTERLEUKIN-2 IN THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA
    STADLER, WM
    VOGELZANG, NJ
    SEMINARS IN ONCOLOGY, 1995, 22 (01) : 67 - 73
  • [30] MYOSITIS ASSOCIATED WITH INTERLEUKIN-2 THERAPY IN A PATIENT WITH METASTATIC RENAL-CELL CARCINOMA
    ESTEVALORENZO, F
    JANIK, JE
    FENTON, RG
    EMSLIESMITH, A
    ENGEL, AG
    LONGO, DL
    CANCER, 1995, 76 (07) : 1219 - 1223